Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 19;11:6453. doi: 10.1038/s41598-021-85733-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Phosphorylation of S6K1 at Thr³⁸⁹ (A), kinase activity of S6K1 (B), phosphorylation of 4E-BP1 at Thr^37/46 (C), the total amount of 4E-BP1 immuoprecipitated together with eIF4E (D), phosphorylation of mTOR at Ser²⁴⁴⁸ (E), eEF2 at Thr⁵⁶ (F), AMPK at Thr¹⁷² (G) and p38 at Thr¹⁸⁰/Tyr¹⁸² (H) at different stages of both trials. The values presented are means ± SD for 8 subjects. *P < 0.05 vs. Rest, ^#P < 0.05 vs. the R-Arm trial. Symbols denoted with a line represent a main effect. Symbols without a line represent an interaction effect with corresponding significant differences in the post-hoc analysis. Representative immunoblots (from strips of full-length blots) of both phosphorylated (upper panel, except for IP) and total protein (lower panel) from one subject are shown above each graph. The two sets of bands have been rearranged, and separated with a white space, to fit the order of the trials in the graphs. Pre = baseline, Post = immediately after exercise, 90 and 180 min = length of recovery.